Rare genes yield new hope for managing pain without opioids By: CNBC.com News November 17, 2017 at 14:12 PM EST Steve Pete and Reid Millius, with mirror-image genetic mutations, are helping companies develop better pain medicines. Read More >> Related Stocks: Amgen Biogen Idec Regeneron Pharmaceuticals Rogers Corp